Teva Pharmaceuticals USA, Inc. is the U.S. arm of a large pharmaceutical manufacturer. Its filings show it lobbies Congress on strengthening domestic manufacturing and supply of essential medicines and on pharmacy-related issues. It reported $200,000 in lobbying across two filings, most recently on 2026-01-15, and used David Friedman as a lobbyist.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
DAVID FRIEDMAN
The latest disclosures for this client.
MR. DAVID FRIEDMAN
Q2YMR. DAVID FRIEDMAN
Q1The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
MR. DAVID FRIEDMAN
MR. DAVID FRIEDMAN
Q4MR. DAVID FRIEDMAN
RR